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Background: The twofold aim of this experimental study was (1) to verify the 
correlation between the duration of ischemia nd concentration fcardiac 
troponin I and (2) to compare the release of cardiac troponin I with 
histologic findings. Methods: Experiments were done on 18 rat hearts, which 
were perfused according to the Langendorff method, immediately after 
excision in group I (control group) and after immersion for 3 hours (group 
II) and 6 hours (group III) in St. Thomas' Hospital solution at 4 ° C. During 
reperfusion, the release of cardiac troponin I, creatine kinase isoenzyme 
MB, and lactate dehydrogenase, the recovery of left ventricular pressure, 
and heart rates were compared among the three groups. After the experi- 
ment, three samples of myocardium (left ventricle, right ventricle, and 
septum) were taken for histologic examination. Results: Cardiac troponin I 
concentration was significantly higher in group III than in groups I and II 
and in group II compared with group I. Cardiac troponin I concentration 
increased as the ischemic period increased, The relation between cardiac 
troponin I release and ischemic duration tended to be linear. Creatine 
kinase MB and lactate dehydrogenase concentrations did not differ from 
one group to the other. Left ventricular pressure was not significantly 
different among the groups. In the control group, no heart had more than 
10% of the myocytes affected. One of six hearts in group II and three of six 
in group IIl had more than 10% of myocytes affected. Conclusion: This 
experimental study showed (1) that cardiac troponin I is an early marker of 
ischemic injury and (2) that cardiac troponin I concentration i creases as 
the ischemic period increases. Early cardiac troponin I release appears to 
correlate with the extent of ischemic injury in rats undergoing buffer 
perfusion. (J Thorac Cardiovasc Surg 1996;112:508-13) 
C ardiac troponin I has already been shown to be a highly specific marker of acute myocardial in- 
farction 1-4 and of reperfusion after thrombolytic 
therapy. 1 We 5 previously reported cardiac troponin 
I to be a marker of perioperative myocardial isch- 
emia. In a group of 20 patients undergoing aortic 
valve replacement for pure aortic Stenosis with 
normal coronary arteries, a positive significant cor- 
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relation existed between aortic crossclamp time and 
cardiac troponin I concentration at hour 6. This 
correlation was modest (r = 0.6). The twofold aim of 
this experimental study was (1) to verify the corre- 
lation between the duration of ischemia nd concen- 
tration of cardiac troponin I and (2) to compare 
cardiac troponin I release with histologic findings. 
Methods 
Experimental protocol. Eighteen male Wistar rats, 
weighing 400 to 450 gin, were anesthetized intraperitone- 
ally with urethane 1 gm/kg. After intravenous administra- 
tion of sodium heparin (500 IU), the aorta was cross- 
clamped and a St. Thomas' Hospital cardioplegic solution 
at 4°C was injected into the aortic root until ischemic 
arrest occurred. The heart was then excised. 
Hearts from the 18 rats were divided into three exper- 
imental groups. In group I, the hearts were suspended 
immediately on the perfusion apparatus by attaching the 
aorta to the perfusion cannula nd were perfused accord- 
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ing to the Langendorff method with an oxygenated Krebs- 
Henseleit bicarbonate buffer containing (in millimoles per 
liter) NaC1 118.0, KC1 4.7, CaC12 1.25, MgSO 4 1.2, 
KH2PO 4 1.2, NaHCO 3 25.0, and glucose 11.0. The solu- 
tion was equilibrated at 37 ° C with 95% oxygen and 5% 
carbon dioxide. The hydrostatic perfusion pressure was set 
at 120 cm H20. A water-filled latex balloon connected to 
a tube was inserted and positioned in the left ventricle 
through the left atrium for measurement of the left 
ventricular pressure (LVP). End-diastolic pressure was set 
at 10 cm H20. If necessary, the heart was defibrillated. In
group II, this procedure was performed after 3 hours of 
immersion in a St. Thomas' Hospital solution at 4 ° C. In 
group III, the hearts were immersed in St. Thomas' 
Hospital solution for 6 hours. 
The hearts were allowed to stabilize for 30 minutes. 
Effluent samples were collected at baseline and 20, 40, 60, 
90, and 120 minutes after stabilization. During reperfu- 
sion, the release of cardiac troponin I, creatine kinase 
isoenzyme MB (CK-MB), and lactate dehydrogenase 
(LD), the recovery of LVP, and heart rates were com- 
pared among the three groups at each collection. 
Histologic analysis. After the experiment, each heart 
was cut open and segments of right and left ventricles and 
septum were :removed immediately. All segments were 
fixed for morphologic study in cacodylate-buffered 2%
glutaraldehyde, postflxed in 1% osmium tetroxide phos- 
phate buffer, dehydrated, and then embedded in Epon 
fixative. Semithin sections (1/xm thick) were prepared and 
stained with alkaline toluidine blue for light microscopic 
study. Three samples of each segment removed were 
studied for each heart. The affected myocytes, isolated or 
grouped, appeared to be swollen with or without contrac- 
tion bands. 
Two histologic groups were defined. Group A included 
hearts in which fewer than 10% of the myocytes were 
affected (n = 14). Group B included hearts having at least 
one sample in which more than 10% of the myocytes were 
affected (n = 4). 
Assay of cardiac troponin I, CK-MB, and LD. Cardiac 
troponin I concentrations were measured by an enzyme- 
linked immunoenzymetric assay developed by ERIA Di- 
agnostics Pasteur (Marne-la-Coquette, France). The assay 
is based on a sandwich technique that allows a quantita- 
tive determination f the cardiac troponin I in serum. The 
solid phase is a polystyrene tube coated with an anticar- 
diac troponin I monoclonal antibody (MAb 8E1). Reve- 
lation is performed with a second anticardiac troponin I
monoclonal antibody (MAb 11E12). Each monoclonal 
antibody is directed at a different peptide sequence of 
cardiac troponin I. 6 The colored reaction occurs only if 
both monoclonal antibodies are bound to the protein. The 
absorbance was read at 450 nm on the status spectropho- 
tometer. Results were expressed as micrograms per liter. 
The method used for CK-MB assay was based on 
Rosalki's pectrophotometric procedure. 7 Serum samples 
were incubated with a CK-MB reagent containing an 
antibody specific to the CK-M subunit that completely 
inhibits the CK-M monomer. The activity of the CK-B, 
which was not inhibited by the antibody, was determined 
after a reaction sequence, by measuring the rate of change 
in absorbance measured at 340 nm. 
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Fig. 1. Time course of cardiac troponin I, CK-MB, and 
LD release in the control group (group I, black circles), in 
the group with 3 hours of ischemia (group II, black 
triangles), and in the group with 6 hours of ischemia 
(group II], black diamonds). The curves of cardiac tropo- 
nin I are significantly higher in group III than in groups I
and I1 and in group II compared with group I (p < 0.01). 
During the time course, within each group, the variation 
of cardiac troponin I is not significant. The curves of 
CK-MB and LD do not differ (p > 0.20) from one group 
to the other. 
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Fig. 2. Time course of left ventricular pressure and heart 
rate in the control group (group I, black circles), in the 
group with 3 hours of ischemia (group II, black triangles), 
and in the group with 6 hours of ischemia (group III, black 
diamonds). The heart rate curve is significantly higher in 
group II than in group III. The left ventricular pressure 
curve does not significantly differ from one group to the 
other. 
The method used for LD assay was based on Wrob- 
lewski and LaDue's spectrophotometric procedure. 8 LD 
catalyzes the conversion of pyruvate to L-lactate while the 
reduced form of nicotinamideadenine dinucleotide is ox- 
idized. The rate of oxidation is proportional to LD 
activity. The activity is monitored by measuring the de- 
crease in absorbance at340 nm. Results are expressed as 
international units per liter. 
Statistical analysis. Values are expressed as mean + 
standard error of the mean. The averages of cardiac 
troponin I, CK-MB, LD, LVP, and heart rate among the 
groups were compared by means of a one-way analysis of 
variance. When F values indicated that significant differ- 
ences were present, we then used Bonferroni's significant 
difference method, which adjusts for multiple compari- 
sons, to compare samples for statistical significance. 
A test for linear trend was carried out for cardiac 
troponin |, CK-MB, and LD concentrations throughout 
the course of the three ordered periods of ischemia. The 
closeness of the association between two variables is 
usually measured by the product-moment correlation 
coefficient r. The use of this statistic might be thought 
objectionable, particularly when the measurements to be 
analyzed are qualitative, although ordered. 9 Conversely, 
instead of analyzing differences between group means, we 
may want to look for trends across the means, provided 
that the levels of the grouping factor are ordered. For 
example, asignificant linear trend would indicate that the 
means increase or decrease in a linear fashion. 
The total amount of cardiac troponin I released uring 
the reperfusion i groups A and B was compared with the 
Wilcoxon rank sum test. The statistical analysis was per- 
formed with BMDP statistical software (BMDP Corp., 
Los Angeles, Calif.). 
Resu l ts  
No stunning occurred during early reperfusion. 
Fig. 1 shows the time course of cardiac troponin I, 
CK-MB, and LD release in each group. Analysis of 
variance shows that the curves were significantly 
different only for cardiac troponin I (p < 0.01). The 
concentration of cardiac troponin I was significantly 
higher at each collection in group III than in groups 
I and II and in group II compared with group I. 
Within each group, there was a small, nonsignif- 
icant variation of cardiac troponin I during the time 
course. Cardiac troponin I concentration i creased 
as the ischemic period increased. Statistical analysis 
revealed that the relation between cardiac troponin 
I release and ischemic duration tended to be linear 
(p ranged from 0.00001 to 0.004 depending on the 
time of collection). CK-MB and LD concentrations 
were not linked to the duration of ischemia. LVP 
was not significantly different among groups. Heart 
rate was significantly higher in group II than in 
group III (Fig. 2). 
Rat weight, heart weight, the amount of St. 
Thomas' Hospital solution injected into the aortic 
root, and the number of shocks necessary to defi- 
brillate the hearts were not significantly different 
from one group to the other (data not shown). 
In the control group, no heart had more than 10% 
of the myocytes affected. One heart of six in group II 
and three of six in group III had more than 10% of 
the myocytes affected. 
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Total release of cardiac troponin I during reper- 
fusion was clearly higher in group B than in group A 
(4.85 __ 1.23 /xg versus 2.37 _+ 0.50 /xg). This 
difference was not significant (p = 0.09) because of 
the number of hearts in each group (14 in group A 
versus 4 in group B). 
Discussion 
Validation of Diagnostics Pasteur cardiac tropo- 
nin I assay in rats. To the best of our knowledge, 
this is the first report on cardiac troponin I release in 
an experimental study involving rats and using the 
Diagnostic Pasteur assay. Thus the use of this par- 
ticular cardiac troponin I assay in rats has not been 
validated. Two arguments may show this assay to be 
valid in rats. First, the amino acid sequences of 
cardiac troponin I in rats and in human beings have 
been reported elsewhere, m Comparison of peptides 
at which the two monoclonal ntibodies are directed 
showed that the peptide that corresponds to MAb 
llE12 is identical in rats and in humans beings, 6
whereas the peptide that corresponds to MAb 8El 
differs from one to the other by only one amino acid. 
As mentioned earlier, the colored reaction occurs 
only if both monoclonal ntibodies are bound to the 
protein. Second, we performed a preliminary study, 
in the same manner as explained in the Methods 
section, to show whether this assay was able to 
detect cardiac troponin I in the coronary effluent 
from isolated rat hearts during reperfusion and to 
study cardiac troponin I release in acute myocardial 
infarction. In the control group (n = 6), the hearts 
were suspended immediately on the perfusion ap- 
paratus. In the ligation group (n = 6), the hearts 
were suspended on the perfusion apparatus imme- 
diately after ligation of the first diagonal artery. 
Results showed that cardiac troponin I was detect- 
able in the coronary effluent from isolated rat hearts 
and that its concentration was significantly higher in 
the ligation group than in the control group (0.40 _+ 
0.25/xg/L versus 0.06 _+ 0.05/xg/L, respectively;p < 
0.05) in al! samples taken within 2 hours of reper- 
fusion. Although the analogy of sequences and the 
preliminary study do not present acertitude, they do 
lead to a strong presumption that this assay is valid 
in rats. 
Cardiac troponin I release and myocardial in- 
farction. Cardiac troponin I has been shown to be a 
reliable marker in myocardial infarction. 1-4 This 
marker is more specific than CK-MB, LD, and 
myoglobin. 11]In cardiac surgery, cardiac troponin I is 
efficient in the diagnosis of perioperative myocardial 
infarction. Mair and associates 12 showed that car- 
diac troponin I increased in all patients after coro- 
nary artery bypass grafting, but the concentrations 
were higher (>3.0 ~g/L at 12 hours) in patients with 
perioperative myocardial infarction. Serum levels of 
cardiac troponin I were lower in perioperative non- 
Q-wave myocardial infarction than in perioperative 
Q-wave myocardial infarction. 12 
Cardiac troponin I and myocardial injury. The 
fact that cardiac troponin I increased in all patients 
after coronary bypass reflected the inevitable myo- 
cardial damage caused by cardioplegic arrest, la 
which tends to demonstrate hat cardiac troponin I 
could also be a marker of myocardial ischemia. In a 
previous tudy, we 5 compared postoperative cardiac 
troponin I concentrations in patients undergoing 
aortic valve replacement with normal coronary ar- 
teries and the concentrations i  patients undergoing 
coronary bypass. Results showed the cardiac tropo- 
nin I concentration to be significantly higher at hour 
6 in the coronary bypass group than in the valve 
replacement group. Moreover, in the valve replace- 
ment group there was a linear correlation between 
cardiac troponin I concentration at hour 6 and 
aortic crossclamp time. Although statistically signif- 
icant (p < 0.01), this correlation was modest (r = 
0.6). No such relationship existed in patients under- 
going coronary bypass because, as opposed to aortic 
valve replacement, wherein myocardial ischemia is 
only due to cardioplegic arrest, in bypass grafting its 
cause is multifactorial. Mair and colleagues, la in the 
study concerning patients undergoing coronary ar- 
tery bypass grafting, concluded that a wide range of 
myocardial damage, even in nonperioperative myo- 
cardial infarction, is common and not always indi- 
cated by CK-MB mass or activity. Cardiac troponin 
I measurements can detect these small differences in
myocardial tissue damage. 
Adams and coworkers ~3 showed a good percent- 
age of concordance between cardiac troponin I and 
CK-MB release after acute myocardial infarction. In 
his study, five patients without myocardial infarction 
and no increase of CK-MB had increased cardiac 
troponin I concentration. Each of these five patients 
had had episodes of angina before the symptoms 
that led to their hospitalization. The increase of 
cardiac troponin I in these patients may have been 
due to myocardial injury related to unstable an- 
gina. 
The aim of this study was to show whether there 
was a link between the duration of ischemia nd the 
release of cardiac troponin I in an experimental 
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model of isolated rat hearts. A histologic examina- 
tion was performed to evaluate myocardial injury. 
Cell repartition of cardiac troponin I and release 
kinetics. Cardiac troponin I circulating levels are 
normally low, but they rise relatively rapidly after 
acute myocardial infarction, suggesting the presence 
of a more accessible pool, perhaps troponin synthe- 
sized in the cytosol, a4 For Haider and Stimson, a5 the 
relatively early release of cardiac troponin I could be 
the result of rapid myofibrillar breakdown, but it 
may also reflect he presence of free cardiac tropo- 
nin I within the sarcoplasm that has not yet been 
incorporated into the myofibrillar texture. Adams 
and associates a3studied the distribution of cardiac 
troponin I in human heart tissue. The cytosol frac- 
tion was 3% and the myofibril fraction was 97%. 
Similar percentages of cardiac troponin I were mea- 
sured in the fractions of cows and dogs. Cardiac 
troponin I shows a prolonged biphasic release pat- 
tern, which is probably the result of the loss of the 
cytoplasmic pool in the first instance and possibly 
derived from myofibrillar degradation i the latter. 
In our study, the concentration of cardiac tropo- 
nin I was significantly higher in group III than in 
groups I and II and in group II compared with group 
I. 
The concentration ofcardiac troponin I increased 
as the ischemic period increased. CK-MB and LD 
concentrations did not show a similar evolution. 
They did not increase significantly as the ischemic 
period increased; in particular, CK-MB concentra- 
tion was similar after 3 hours and after 6 hours of 
ischemia. Cardiac troponin I concentration was 
nearly identical in all samples taken during reperfu- 
sion, whereas CK-MB and LD concentrations de- 
creased rapidly. These observations tend to demon- 
strate either that CK-MB and LD are not reliable 
markers of myocardial ischemia or that their release 
is less rapid, mainly because of their higher molec- 
ular weight (CK-MB 80,000 kd, LD 180,000 kd, and 
cardiac troponin I 28,000 kd). 16 Indeed, in buffer 
systems uch as the Langendorff preparation, early 
measurements reflect the cytosolic release of pro- 
teins, and proteins with a lower molecular weight 
are released faster. Sampling late after reperfusion 
would have made it possible to prove whether or not 
CK-MB and LD are indeed markers of myocardial 
ischemia. Other studies, sampling later, showed that 
CK and LD concentrations peaked 5 minutes after 
reperfusion and decreased rapidly thereafter, a7' as 
Release kinetics of CK and LD in the Langendorlf 
preparation of isolated rat hearts. Yamahara and 
colleagues 17 designed a study in which ischemic 
duration was 20 and 60 minutes at 37 ° C. The 
release kinetics of CK and LD showed a monopha- 
sic pattern. The peaks in CK and LD release oc- 
curred just 5 minutes after stabilization of the 
hearts, and the levels after 4 hours of reperfusion 
returned to baseline levels. In the study by Remppis 
and coworkers, as the hearts were damaged either by 
the calcium paradox or by 60 minutes of no-flow 
ischemia. Peak levels occurred 5 minutes after the 
onset of reperfusion with calcium-containing buffers 
and returned to 1.3% (CK) and 1% (LD) of their 
respective peak levels within 55 minutes of reperfu- 
sion. During no-flow ischemia, CK and LD rapidly 
declined to 18% (CK) and 23% (LD) of their 
respective 5-minute values at the end of reperfusion. 
The release kinetics of CK-MB and LD are similar 
in our study. 
Fig. 1 shows that CK-MB and LD concentrations 
were maximal at the end of stabilization and de- 
creased thereafter until the sample taken at 90 
minutes. The values of CK-MB at 120 minutes eem 
to be nonrelevant inasmuch as the dispersion of the 
values was important, as shown by the large confi- 
dence interval. 
Myocardial injury and infarction. As stated ear- 
lier, our measurements probably reflected only the 
cytosolic release of cardiac troponin I and not the 
troponins that are bound to the contractile appara- 
tus. Therefore we cannot differentiate injury from 
infarction. The histologic study showed that the 
increase of cardiac troponin I might effectively 
correspond to a myocardial injury. When cardiac 
troponin I concentrations in hearts in which more 
than 10% of myocytes were affected (group B) were 
compared with hearts in which fewer than 10% of 
myocytes were affected (group A), the concentration 
of cardiac troponin I was clearly higher in group B. 
Even if the difference was not statistically significant 
because of the small number of hearts included in 
group B, there was a tendency to confirm the 
sensitivity of cardiac troponin I to myocardial injury. 
Inasmuch as the histologic study was performed too 
early, it could not discriminate between cells that 
are viable, but ischemically injured, as opposed to 
necrotic. Results showed similar and substantial 
LVPs among the three groups despite he long 
duration of ischemia (6 hours) for some of them. 
The statistically significant difference in heart rate 
between group II and group III (330 _+ 16 versus 
280 _+ 11 beats/rain, respectively) is of no clinical 
significance. 
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Conclusion 
This experimental study showed that (1) cardiac 
troponin I is an early marker of ischemic injury and 
(2) cardiac troponin I concentrat ion i creases as the 
ischemic period increases. Statistical analysis re- 
vealed that the relation between ischemic durat ion 
and cardiac t ropon in  I release tended to be l inear. 
Early cardiac t ropon in  I release appears to corre- 
late with the extent of ischemic injury in rats 
undergo ing buffer perfusion. Fur ther  evaluat ion 
of the release of these cardiac markers in other 
animal  preparat ions  and in human beings could be 
useful to assess myocardial  protect ion dur ing car- 
diac operat ions.  
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